SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (210)5/14/1999 3:14:00 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 555
 
I'm paralyzed. :-) (eom)



To: LLCF who wrote (210)5/14/1999 3:26:00 PM
From: scaram(o)uche  Respond to of 555
 
renegotiation was a crummy term. they simply didn't pick up the option. But, the impact is the same..... JNJ was picking up half the tab for clinicals, and they won't be doing such now.

Again, I don't know if this will be the end of the drug, after the huffing and puffing is done, or if this could be a windfall.

Enough said, as I don't know the company or product well. Just wanted to clarify.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News